• Register
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.


Leaving Community

Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.


Protein kinase D isoforms are expressed in rat and mouse primary sensory neurons and are activated by agonists of protease-activated receptor 2.

Serine proteases generated during injury and inflammation cleave protease-activated receptor 2 (PAR(2)) on primary sensory neurons to induce neurogenic inflammation and hyperalgesia. Hyperalgesia requires sensitization of transient receptor potential vanilloid (TRPV) ion channels by mechanisms involving phospholipase C and protein kinase C (PKC). The protein kinase D (PKD) serine/threonine kinases are activated by diacylglycerol and PKCs and can phosphorylate TRPV1. Thus, PKDs may participate in novel signal transduction pathways triggered by serine proteases during inflammation and pain. However, it is not known whether PAR(2) activates PKD, and the expression of PKD isoforms by nociceptive neurons is poorly characterized. By using HEK293 cells transfected with PKDs, we found that PAR(2) stimulation promoted plasma membrane translocation and phosphorylation of PKD1, PKD2, and PKD3, indicating activation. This effect was partially dependent on PKCepsilon. By immunofluorescence and confocal microscopy, with antibodies against PKD1/PKD2 and PKD3 and neuronal markers, we found that PKDs were expressed in rat and mouse dorsal root ganglia (DRG) neurons, including nociceptive neurons that expressed TRPV1, PAR(2), and neuropeptides. PAR(2) agonist induced phosphorylation of PKD in cultured DRG neurons, indicating PKD activation. Intraplantar injection of PAR(2) agonist also caused phosphorylation of PKD in neurons of lumbar DRG, confirming activation in vivo. Thus, PKD1, PKD2, and PKD3 are expressed in primary sensory neurons that mediate neurogenic inflammation and pain transmission, and PAR(2) agonists activate PKDs in HEK293 cells and DRG neurons in culture and in intact animals. PKD may be a novel component of a signal transduction pathway for protease-induced activation of nociceptive neurons and an important new target for antiinflammatory and analgesic therapies.

Pubmed ID: 19575452


  • Amadesi S
  • Grant AD
  • Cottrell GS
  • Vaksman N
  • Poole DP
  • Rozengurt E
  • Bunnett NW


The Journal of comparative neurology

Publication Data

September 10, 2009

Associated Grants

  • Agency: Wellcome Trust, Id: 071987
  • Agency: Biotechnology and Biological Sciences Research Council, Id: BB/E527098/1
  • Agency: NIDDK NIH HHS, Id: DK39957
  • Agency: NIDDK NIH HHS, Id: DK43207
  • Agency: NIDDK NIH HHS, Id: DK57840
  • Agency: NIDDK NIH HHS, Id: R01 DK057840
  • Agency: NIDDK NIH HHS, Id: R01 DK057840-09

Mesh Terms

  • Animals
  • Cell Line
  • Cell Membrane
  • Cells, Cultured
  • Enzyme Activation
  • Ganglia, Spinal
  • Humans
  • Isoenzymes
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Neuropeptides
  • Nociceptors
  • Protein Kinase C
  • Protein Kinases
  • Rats
  • Rats, Sprague-Dawley
  • Receptor, PAR-2
  • Sensory Receptor Cells
  • TRPV Cation Channels